EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES

被引:31
|
作者
Weeks, Laura [1 ]
Polisena, Julie [1 ]
Scott, Anna Mae [2 ]
Holtorf, Anke-Peggy [3 ]
Staniszewska, Sophie [4 ]
Facey, Karen [5 ]
机构
[1] Canadian Agcy Drugs & Technol Hlth CADTH, Ottawa, ON, Canada
[2] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld, Australia
[3] Hlth Outcomes Strategies GmbH, Basel, Switzerland
[4] Univ Warwick, Coventry, W Midlands, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
Patient involvement; Public involvement; Evaluation; PERSPECTIVES; DECISIONS; CONSUMERS; IMPACT; POLICY;
D O I
10.1017/S0266462317000976
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Although there is increased awareness of patient and public involvement (PPI) among health technology assessment (HTA) organizations, evaluations of PPI initiatives are relatively scarce. Our objective as members of Health Technology Assessment International's (HTAi's) Patient and Citizen Involvement Group (PCIG) was to advance understanding of the range of evaluation strategies adopted by HTA organizations and their potential usefulness. Methods: In March 2016, a survey was sent to fifty-four HTA organizations through the International Network of Agencies for Health Technology Assessment (INAHTA) and contacts of members of HTAi's PCIG. Respondents were asked about their organizational structure; how patients and members of the public are involved; whether and how PPI initiatives have been evaluated, and, if so, which facilitators and challenges to evaluation were found and how results were used and disseminated. Results: Fifteen (n = 15) programs from twelve countries responded (response rate 27.8 percent) that involved patients (14/15) and members of the public (10/15) in HTA activities. Seven programs evaluated their PPI activities, including participant satisfaction (5/7), process (5/7) and impact evaluations (4/7). Evaluation results were used to improve PPI activities, identify education and training needs, and direct strategic priorities. Facilitators and challenges revolved around the need for stakeholder buy-in, sufficient resources, senior leadership, and including patients in evaluations. Conclusions: A small but diverse set of HTA organizations evaluate their PPI activities using a range of strategies that reflect the range of rationales and approaches to PPI in HTA. It will be important for HTA organizations to draw on evaluation theories and methods.
引用
收藏
页码:715 / 723
页数:9
相关论文
共 50 条
  • [1] EVALUATION OF PATIENT INVOLVEMENT IN A HEALTH TECHNOLOGY ASSESSMENT
    Dipankui, Mylene Tantchou
    Gagnon, Marie-Pierre
    Desmartis, Marie
    Legare, France
    Piron, Florence
    Gagnon, Johanne
    Rhiands, Marc
    Coulombe, Martin
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2015, 31 (03) : 166 - 170
  • [2] Patient and public involvement in health technology assessment: update of a systematic review of international experiences
    Gagnon, Marie-Pierre
    Dipankui, Mylene Tantchou
    Poder, Thomas G.
    Payne-Gagnon, Julie
    Mbemba, Gisele
    Beretta, Valentina
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [3] "It all depends": Conceptualizing public involvement in the context of health technology assessment agencies
    Gauvin, Francois-Pierre
    Abelson, Julia
    Giacomini, Mita
    Eyles, John
    Lavis, John N.
    [J]. SOCIAL SCIENCE & MEDICINE, 2010, 70 (10) : 1518 - 1526
  • [4] PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FORACTION
    Abelson, Julia
    Wagner, Frank
    DeJean, Deirdre
    Boesveld, Sarah
    Gauvin, Francois-Pierre
    Bean, Sally
    Axler, Renata
    Petersen, Stephen
    Baidoobonso, Shamara
    Pron, Gaylene
    Giacomini, Mita
    Lavis, John
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (04) : 256 - 264
  • [5] Patient and public involvement in Health Technology Assessment: a new dawn?
    Werko, Sophie Soderholm
    Staniszewska, Sophie
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [6] Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
    Goetghebeur, Mireille
    Cellier, Marjo
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2021, 10 (04) : 228 - 231
  • [7] A framework for action to improve patient and public involvement in health technology assessment
    Silva, Aline Silveira
    Facey, Karen
    Bryan, Stirling
    Galato, Dayani
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 38 (01)
  • [8] Development of the International Network of Agencies for Health Technology Assessment
    Hailey, David
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 : 24 - 27
  • [9] An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations
    Whitty, Jennifer A.
    [J]. VALUE IN HEALTH, 2013, 16 (01) : 155 - 163
  • [10] International Network of Agencies for Health Technology Assessment (INAHTA) or the need for collaboration in the evaluation of health technologies
    Batarrita, JA
    [J]. MEDICINA CLINICA, 1999, 112 : 86 - 89